ArticleClinical pharmacology and therapeutics2017

Response to "Pharmacogenetics of Voriconazole: CYP2C19 but Also CYP3A4 Need to Be Genotyped" - The Role of CYP3A4 and CYP3A5 Polymorphisms in Clinical Pharmacokinetics of Voriconazole.

T J Walsh et al.PubMed ↗Publisher ↗

No numbers read from the abstract.